Direct costs and survival of medicare beneficiaries with early and advanced Parkinson's disease

scientific article published on 16 December 2011

Direct costs and survival of medicare beneficiaries with early and advanced Parkinson's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.PARKRELDIS.2011.11.015
P698PubMed publication ID22177623

P2093author name stringA D Siderowf
S J Johnson
M R Davis
H G Birnbaum
A Kaltenboeck
C A Carroll
M L Tarrants
P433issue4
P921main subjectParkinson's diseaseQ11085
P1104number of pages6
P304page(s)321-326
P577publication date2011-12-16
P1433published inParkinsonism and Related DisordersQ15762600
P1476titleDirect costs and survival of medicare beneficiaries with early and advanced Parkinson's disease
P478volume18

Reverse relations

cites work (P2860)
Q37132304Costs of Parkinson's disease in a privately insured population
Q37625733Improved survival outcomes in cancer patients with hereditary hemorrhagic telangiectasia
Q45872896Lancet Commission: Stem cells and regenerative medicine.
Q24194581Mind-body movement therapies for Parkinson's disease
Q41294649PPNa-DBS for gait and balance disorders in Parkinson's disease: a double-blind, randomised study
Q38111335Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease
Q38082649Progressive resistance exercise improves strength and physical performance in people with mild to moderate Parkinson's disease: a systematic review
Q37710224Systematic Review and Critical Analysis of Cost Studies Associated with Parkinson's Disease
Q35555805The cyclical lower extremity exercise for Parkinson's trial (CYCLE): methodology for a randomized controlled trial
Q35772039Validation of an ambulatory capacity measure in Parkinson disease: a construct derived from the Unified Parkinson's Disease Rating Scale
Q64863539What predicts falls in Parkinson disease?: Observations from the Parkinson's Foundation registry

Search more.